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Abstract
A recent genome-wide association study of lung cancer among never-smoking females in Asia demonstrated that the
rs2736100 polymorphism in the TERT-CLPTM1L locus on chromosome 5p15.33 was strongly and significantly associated with
risk of adenocarcinoma of the lung. The telomerase gene TERT is a reverse transcriptase that is critical for telomere
replication and stabilization by controlling telomere length. We previously found that longer telomere length measured in
peripheral white blood cell DNA was associated with increased risk of lung cancer in a prospective cohort study of smoking
males in Finland. To follow up on this finding, we carried out a nested case-control study of 215 female lung cancer cases
and 215 female controls, 94% of whom were never-smokers, in the prospective Shanghai Women’s Health Study cohort.
There was a dose-response relationship between tertiles of telomere length and risk of lung cancer (odds ratio (OR), 95%
confidence interval [CI]: 1.0, 1.4 [0.8–2.5], and 2.2 [1.2–4.0], respectively; P trend = 0.003). Further, the association was
unchanged by the length of time from blood collection to case diagnosis. In addition, the rs2736100 G allele, which we
previously have shown to be associated with risk of lung cancer in this cohort, was significantly associated with longer
telomere length in these same study subjects (P trend= 0.030). Our findings suggest that individuals with longer telomere
length in peripheral white blood cells may have an increased risk of lung cancer, but require replication in additional
prospective cohorts and populations.
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Introduction
Telomerase gene TERT is a reverse transcriptase that is critical
for telomere replication and stabilization by controlling telomere
length. Telomeres are DNA–protein complexes that cap the ends
of chromosomes and promote chromosomal stability. To date, the
associations between telomere length and cancer risk are
inconclusive. Most initial studies used a case-control design and
reported that shorter telomere length measured in peripheral
white blood cells was associated with increased risk of cancer [1].
In contrast, some recent publications using a prospective cohort
design have suggested that longer telomere length may be
associated with increased risk of certain tumors, including lung,
lymphoma, hepatocellular carcinoma, and melanoma [2–5].
Recently, two case-control studies reported that longer telomere
length was associated with colorectal, breast cancer, and breast
cancer survival [6–9]. Shorter telomere length has been associated
with aging and both shorter and longer telomere length have been
associated with risk of a number of chronic diseases [10,11],
although this heterogeneity may be explained in part by case-
control vs. prospective cohort study designs. In addition, telomere
length is strongly mediated by genetic factors with an estimated
heritability ranging from 44% to 80% [12,13]. Several studies
have identified a number of polymorphisms that were associated
with telomere length [8,14–17], but a comprehensive understand-
ing of the genetic contribution to telomere length has still not
emerged.
We recently conducted a genome-wide association study
(GWAS) of lung cancer among never-smoking females in Asia
and demonstrated that the rs2736100 polymorphism in the
TERT-CLPTM1L locus on chromosome 5p15.33 was strongly
and significantly associated with risk of adenocarcinoma of the
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lung (P trend= 10220) and is replicated by other GWAS studies
[18–20]. Further, there is additional evidence suggesting that this
locus is associated with other cancers, including cancer of the
bladder, prostate, uterine cervix, pancreas, breast, ovary, testes,
brain, and skin [21–26]. These findings suggest that the TERT-
CLPTM1L 5p15.33 region could play a role in the development of
a wide spectrum of cancers with differing etiologies.
We previously reported that longer telomere length was
associated with risk of lung cancer in the Alpha-Tocopherol,
Beta-Carotene Cancer Prevention (ATBC) prospective cohort [4],
which is comprised of smoking males in Finland. To follow up on
this report in a distinctly different population and to further
explore our genetic findings, we conducted a nested case-control
study of lung cancer cases and controls in the prospective
Shanghai Women’s Health Study cohort (SWHS).
Materials and Methods
Study Subjects
The detailed methods for the SWHS have been described
previously [27]. Briefly, 74,942 Chinese women between the ages
of 40 and 70 years and residing in seven urban communities of
Shanghai were recruited into the cohort study from 1997 to 2000
with a participation rate of 92.7%. Of the study participants,
56,831 (75.8%) provided a blood sample, which was collected
during enrollment into the cohort. The study was approved by the
institutional review boards of all collaborating institutions. Each
study subject provided a consent form at the time of enrollment
and completed a standardized questionnaire including information
on demographic characteristics, medical history, family history of
cancer, tobacco use, residential history including use of cooking oil
and fuel, and exposure to environmental tobacco smoke from their
husband or from colleagues in the workplace. Follow-up for cancer
incidence and mortality was conducted through home visits as well
as linkage to the population-based Shanghai Cancer Registry. For
women who were diagnosed with cancer, medical charts were
reviewed and characteristics of the tumor were recorded. For the
follow-up surveys, the follow-up rates for three different interviews
were 99.8% (2000–2002), 98.7% (2002–2004), and 96.7% (2004–
2007) of cohort members or their next of kin.
We used a nested case-control design for this project. The cases
consist of incident lung cancer cases. Controls were selected from
the SWHS study participants who were alive and free of cancer at
the time of the case diagnosis, and were individually matched to
cases on date of birth (62 years) and date of blood sample
collection (63 month). In total, 215 lung cancer cases and 215
matched controls were included in the current study.
Telomere Assay
DNA was extracted from buffy coats using the phenol-
chloroform method. A monochrome multiplex quantitative PCR
assay was used to determine the telomere measurements [28]. All
assays were carried out at the laboratory of Dr. Richard Cawthon
using the Bio-Rad CFX384 Real-Time PCR Detection System.
Masked replicate samples were interspersed within and across
assay batches to evaluate assay reproducibility. Cases and their
matched controls were assayed consecutively within batches. The
overall coefficient of variation (CV) of replicate samples was 11%
and intraclass correlation coefficient (ICC) was 87%. In brief, the
reagents in the 10 mL PCR were 10 mmol/L Tris-HCl (pH 8.3),
50 mmol/L KCl, 3 mmol/L MgCl2, 0.2 mmol/L each dNTP,
1 mmol/L DTT, 1 mol/L betaine, 0.756 SYBR Green I, and
AmpliTaq Gold DNA polymerase, 0.625 U. The four primers
were (59 to 39): telg (at 100 nmol/L), ACAC-
TAAGGTTTGGGTTTGGGTTTGGGTTTGGGTTAGTGT;
telc (at 900 nmol/L), TGTTAGGTATCCCTATCCCTATC-
CCTATCCCTATCCCTAACA; albugcr2 (at 700 nmol/L), CG-
GCGGCGGGCGGCGCGGGCTGGGCGGCCATGCTTTT-
CAGCTCTGCAAGTC; and albdgcr2 (at 500 nmol/L), GCC-
CGGCCCGCCGCGCCCGTCCCGCCGAGCATTAAGCTC-
TTTGGCAACGTAGGTTTC.
From 5 to 10 ng of human genomic DNA were added per
reaction well. Three-fold serial dilutions of a reference genomic
DNA sample were used to generate two standard curves for each
PCR plate (five concentrations with a high of 40 ng/reaction and
a low of 0.49 ng/reaction). Thermal cycling consisted of 1 cycle of
15 min at 95uC; 2 cycles of 2 s at 98uC, 30 s at 49uC; 36 cycles of
2 s at 98uC, 30 s at 59uC, 15 s at 74uC with signal acquisition,
30 s at 84uC, and 15 s at 85uC with signal acquisition. The 74uC
reads provided the cycle thresholds (Cts) for telomeres; the 85uC
reads provided the Cts for the single copy gene (albumin). After the
run was complete, the Bio-Rad CFX Manager Software was used
to determine the T (telomere) and S (single copy gene) values for
each experimental sample by the Standard Curve method.
All samples were assayed in triplicate. The ratio of the telomere
PCR signals to the single copy gene (in our case, b-globin) PCR
signal (i.e. the T/S ratio) is proportional to the average telomere
length of all the cells in a sample. T/S values are relative average
telomere lengths, expressed relative to the T/S value of the
reference standard DNA sample, which by definition is 1.00. The
standard DNA sample used for our studies has an actual average
telomere length of approximately 3300 base pairs [28]. For a given
experimental sample, the T value is the number of nanograms of
the reference DNA that matches the experimental sample for copy
number of the telomere template, and the S value is the number of
nanograms of the reference DNA that matches the experimental
sample for copy number of the single copy gene template. T/S,
therefore, is a relative and dimensionless value. Samples with a T/
S.1.0 have an average telomere length greater than that of the
standard DNA; samples with a T/S,1.0 have an average
telomere length shorter than that of the standard DNA. Multiplex
quantitative PCR eliminates a major source of variation present in
monoplex quantitative PCR. In monoplex quantitative PCR,
variation in the amount of DNA pipetted into the T and S reaction
wells results in variation in T/S whereas in multiplex quantitative
PCR both T and S are measured in each reaction well, so the
pipetting variation between wells does not affect T/S.
Genotyping
Genotyping was conducted using an optimized TaqMan assay
(ABI, Foster City, CA), at the National Cancer Institute Cancer
Genomics Research (CGR) as previously described [19].
Statistical Analysis
Because the T/S ratios derived from the telomere length data
were not normally distributed, the data were log transformed. The
Wilcoxon signed-rank test was used to test the difference of
telomere length among cases versus controls. The cut points for
the tertiles of telomere length were derived from the distribution in
the controls. Odds ratios (ORs) and 95% confidence intervals
(95% CIs) were estimated using conditional logistic regression
models. Telomere length was modeled as both a continuous and
categorical variable. Tests for trends were calculated using log
transformed telomere length as a continuous variable. Age was
used in all conditional models and account for potential residual
confounding, and smoking status was included in all models that
included ever-smokers. Variables that resulted in a 10% or greater
change in the b-coefficient of the telomere length variable in the
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base model were considered confounders and included in the final,
multivariable models. All P values are 2-sided. We also conducted
a secondary analysis using fractional polynomials to investigate a
possible non-linear association between telomere length and risk of
lung cancer. The optimal degree of smoothing was chosen using a
model selection procedure proposed by Royston and Sauerbrei
[29]. To determine if the association might be driven in part by
elevated telomere length among cases with undiagnosed lung
cancer at the time of blood sample collection, and to determine if
the association persisted for more than 5 years, we stratified the
analyses by time from blood collection to case diagnosis (02,=2,
.2–5, and .5 years) or reference date that the control was
selected. We analyzed the influence of the rs2736100 genotype on
log-transformed telomere length by linear regression, assigning the
ordinal values 1, 2, and 3 for the TT, GT, and GG genotypes,
respectively, and adjusting for age.
Results
The baseline characteristics of the study subjects are shown in
Table 1. The age of cases and controls was comparable and 93%
of cases and 95% of controls were never-smokers. Telomere length
was inversely correlated with age in both cases (Spearman
correlation r =20.39 P,0.0001) and controls (Spearman corre-
lation r =20.41 P,0.0001). No significant correlation was found
between the mean telomere length and demographic parameters
shown in Table 1. In addition, the distribution of telomere length
Table 1. Selected characteristic of lung cancer cases and individually matched controls selected from the Shanghai Women’s
Health Study (recruited between 1997–2000).
Characteristic Controls (N=215) Cases (N=215)
N (%) N (%)
Age at enrollment, y$
40–44 16 (7.44) 15 (6.98)
45–49 23 (10.70) 25 (11.63)
50–54 23 (10.70) 24 (11.16)
55–59 26 (12.09) 26 (12.09)
60–64 44 (20.47) 47 (21.86)
65+ 83 (38.60) 78 (36.28)
Ever Smoking£
Yes 10 (4.65) 16 (7.44)
No 205 (95.35) 199 (92.56)
Passive Smoking£
Yes 161 (74.88) 153 (71.16)
No 33 (15.35) 36 (16.74)
NA{ 21 (9.77) 26 (12.09)
Family history of lung cancer{
Yes 1 (0.47) 3 (1.40)
No 214 (99.53) 212 (98.60)
Year of enrollment
1997 61 (28.37) 53 (24.65)
1998 97 (45.12) 108 (50.23)
1999 47 (21.86) 42 (19.53)
2000 10 (4.65) 12 (5.58)




GG 24 (11.16) 41 (19.07)
GT 103 (47.91) 109 (50.70)
TT 70 (32.56) 43 (20.00)
NA{{ 18 (8.37) 22 (10.23)
$Spearman correlation (r) with telomere length in controls is 20.41(P,0.0001).
£P value of spearman r with telomere length in controls .0.05.
{Family history of lung cancer in first degree relatives.
*NOS indicates not otherwise specified.
{NA indicates not available.
{{NA indicates not available, as only never-smoking subjects were genotyped.
doi:10.1371/journal.pone.0059230.t001
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was statistically significantly longer among cases than controls
[P = 0.032].
The risks of lung cancer by tertiles of telomere length are shown
in Table 2. Subjects in the middle and highest tertiles had higher
risk than did those in the lowest tertile (OR 1.4, 95% CI 0.8–2.5
for the middle tertile; 2.2, 1.2–4.0 for the highest tertile, P
trend= 0.003, Table 2, adjusted for age and ever smoking).
Further adjustment for passive smoking and family history of lung
cancer had a negligible impact on the results (OR 1.4, 95% CI
0.8–2.4 and 2.2, 1.2–4.0 for the middle and highest tertiles,
respectively, P trend= 0.004). Removal of ever-smoking cases and
controls yielded similar results (OR 1.7, 95% CI 0.9–2.9 for the
middle tertile; 2.5, 1.3–4.7 for the highest tertile, P trend= 0.003).
Models including fractional polynomials did not fit the data better
than the simpler linear model (likelihood ratio test p= 0.44). The
latter was thus retained on the ground of parsimony. The observed
associations were similar across different follow-up times (Table 2)
(i.e., time from date of phlebotomy to date of diagnosis), and a test
of heterogeneity for associations across strata of follow-up time was
not significant (P = 0.15). However, due to the small number of
subjects in some strata and the imprecise risk estimates, replication
in studies with larger samples sizes is needed to evaluate potential
heterogeneity. In addition, there was no evidence that the
association between telomere length and risk of lung cancer
varied by age of blood donation (test for heterogeneity: P= 0.96).
We previously reported that rs2736100 on chromosome
5p15.33 was strongly associated with risk of adenocarcinoma of
the lung among never-smokers in this cohort. We therefore studied
the relationship between the genetic data and telomere length in
this population. The mean telomere length in association with
rs2736100 (CLPTM1L-TERT) is shown in Table 3. The rs2736100
G allele, which we previously demonstrated to be associated with
risk of lung cancer in this cohort [19], was significantly associated
with longer telomere length (P trend= 0.03) (Table 3).
Discussion
In this prospective cohort study of mostly never-smoking women
in China, we found that longer telomere length measured in
peripheral white blood cells was significantly and positively
associated with increased risk of lung cancer and this association
was unchanged by the length of time from blood collection to case
diagnosis. Further, the rs2736100 G allele, which we previously
demonstrated to be associated with risk of lung cancer in this
cohort [19], was also significantly associated with longer telomere
length.
Table 2. Telomere length and risk of lung cancer: results for overall study and stratifying by years from enrollment to case
diagnosis.







,1.37 71/54 1.0 12/10 1.0 26/21 1.0 33/23 1.0
1.37–1.60 72/69 1.4(0.8–2.5) 13/8 0.6(0.1–3.0) 32/26 1.3(0.6–3.2) 27/35 2.6(1.0–6.5)
$1.60 72/92 2.2(1.2–4.0) 12/19 4.1(0.7–25.1) 33/44 2.5(0.9–7.1) 27/29 2.3(0.9–5.8)
P trend 0.003{ 0.16{ 0.069{ 0.076{
{Telomere length categorized using tertiles in controls as cut-points.
*NCo indicates number of controls; and NCa, number of cases.
£Odds ratios computed using conditional logistic regression adjusted for age and ever smoking.
{P trend calculated by using log transformed telomere length as continuous variable, adjusted for age and ever smoking.
doi:10.1371/journal.pone.0059230.t002
Table 3. Mean telomere length in association with rs2736100 (CLPTM1L-TERT), by case-control status in the Shanghai Women’s




(%) (%) Cases (%) All{ Cases{ Controls{
TT 70 (36) 43 (22) 1.45(0.30) 1.50(0.34) 1.43(0.28)
GT 103 (52) 109 (56) 1.53(0.29) 1.56(0.30) 1.50(0.29)
GG 24 (12) 41 (21) 1.55(0.33) 1.57(0.37) 1.52(0.25)
P trend{ 0.030 0.20 0.20
Correlation P value£ 0.035 0.38 0.11
*log transformed telomere length as continuous variable was used.
{mean (SD).
{P for trend calculated by using linear regression and rs2736100 by assigning the ordinal values 1, 2, and 3 for TT, GT, and GG respectively, adjusted for age and ever
smoking.
£P value from spearman correlation test.
doi:10.1371/journal.pone.0059230.t003
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Our finding that longer telomere length is associated with lung
cancer risk is consistent with our previous report in the prospective
ATBC Cancer Prevention cohort [4] in male smokers. Both of the
two studies are prospective by design and are the only cohort
studies of telomere length and lung cancer published to date, to the
best of our knowledge. In contrast, some case-control studies have
reported associations between shorter telomere length and lung
cancer risk [30–32] where telomere length was measured in white
blood cells collected at the time of or after diagnosis of cancer. It is
interesting that a report from the same cohort found a U-shaped
association between telomere length and colorectal cancer risk,
suggesting that the relationship between telomere length measured
in peripheral blood leukocytes and risk of various types of cancers
may exhibit different types of dose-response relationships.
The inconsistency between findings in case-control and cohort
studies may be due to a number of reasons. First, telomere length
in peripheral white blood cells could be altered by the presence of
malignant disease. Therefore, the observed association between
shortened telomere length and disease in case-control studies could
be a result of reverse causation bias [16,33]. Secondly, chemo-
therapy or radiation therapy prior to blood collection could cause
DNA damage and might affect telomere length [34,35]. Several of
the case-control studies of cancer did not report the status of the
treatment of the cases. Pooley et al. compared results of telomere
length from samples of both retrospective case-control studies and
prospective cohort studies of breast and colon cancer patients and
found that shorter telomere length was associated with increased
risk in the case-control studies but not in the prospective cohort
studies [16,33]. Blood samples from subjects in our study were
collected one to 10 years prior to diagnosis, and the effects we
report persisted for the longest period of follow-up (i.e., more than
5 to 10 years). Third, accuracy and precision in the measurement
of telomere length is critical in calculating risk of cancer [36] and
variation in these may contribute to inconsistent findings. For
example, plate and location of sample on a plate had a significant
influence on telomere length measurements even though they are
highly correlated between plates within a given individual [36].
The monochrome multiplex quantitative PCR method used in this
report, which was developed by Dr. Richard Cawthon [28],
provides improved consistency compared to other methods [8]. In
our study, Dr. Cawthon’s laboratory conducted the analyses with a
coefficient of variation (CV) of 11%. Also, we enhanced precision
in the measurement of telomere length by putting DNA from cases
and their matched controls next to each other on a given plate.
In principle, either long or short telomeres may raise cancer
risks, depending on the cell’s history of somatic mutations and the
cell’s microenvironment. When the cell cycle checkpoint, cellular
senescence, and apoptosis gene networks are intact, short
telomeres in dividing cells are expected to be protective against
cancer, since further telomere shortening caused by cell division
soon triggers either cellular senescence or apoptosis, preventing
the cell from developing into a cancer cell. Conversely, long
telomeres may raise cancer risk, because the additional rounds of
cell division afforded by the long telomeres provide the cell (and its
daughter cells) the opportunity to accumulate genetic hits (somatic
mutations) that block the pathways to senescence and apoptosis
and promote tumorigenesis. Alternatively, among cells in which
the pathways to cellular senescence and apoptosis are already
blocked, those with shorter telomeres are prone to end-to-end
chromosome fusions and consequent chromosomal instability, a
contributor to carcinogenesis [37,38]. A previous study suggested
that a balance between elongation by telomerase and telomere
shortening is important to produce a stabilized ‘optimal’ length
that is critical for cell proliferation, senescence, and control [39].
The finding of an association between the TERT SNP
rs2736100 and telomere length is intriguing. Rafnar et al. found
that two SNPs on the TERT gene, rs401681C and rs2736098A
alleles, were both significantly associated with shorter telomere
length in never-smoking women between 85 and 95 years old in
Caucasians. However, these associations went in the opposite
direction when limited to younger never-smoking women although
the associations were not significant [23]. Mirabello et al. found no
association between rs2736100 and telomere length in Caucasians
[40]. We note that the rs2736100 and lung cancer association was
stronger among never-smoking women in East Asians than in
Caucasians [19,41]. Further, the risk was also higher compared to
a GWAS of lung cancer in Japanese and Koreans, who were
mostly smokers and male [42]. As such, it is possible that the
relationship between rs2736100 and telomere length itself may
vary by ethnicity, gender, and/or smoking behavior. Interestingly,
in a preliminary analysis that was limited by small numbers, we
found some evidence that the effect of longer telomere length and
greater risk of lung cancer was limited to those individuals carrying
the at risk (GT/GG) genotype of rs2736100 (data not shown). At
the same time, our study is relatively small and the findings need to
be evaluated in additional populations, using telomere length
measured by the same method used here. Further, functional work
is needed to identify the variant that directly accounts for the
underlying association as well as to study the mechanism by which
this genetic variant mediates telomere length.
In summary, our prospective cohort study found that longer
telomere length measured in peripheral white blood cell DNA was
strongly associated with risk of lung cancer in Chinese women, and
is the second cohort study to report an association between longer
telomere length and higher risk of lung cancer. However, these
findings are based on relatively modest sized samples and require
replication in additional cohorts and populations.
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